1,781
Views
1
CrossRef citations to date
0
Altmetric
Cancer Biology

Identification of potential genes correlated with breast cancer metastasis and prognosis

, , , , &
Pages 126-133 | Received 27 Jul 2021, Accepted 16 Dec 2021, Published online: 17 Jan 2022

References

  • Akram M, Iqbal M, Daniyal M, Khan AU. 2017. Awareness and current knowledge of breast cancer. Biol Res. 50:33.
  • Amjad E, Asnaashari S, Sokouti B, Dastmalchi S. 2020. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages. Sci Rep. 10:10816.
  • Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 25:25–29.
  • Bandettini WP, Kellman P, Mancini C, Booker OJ, Vasu S, Leung SW, Wilson JR, Shanbhag SM, Chen MY, Arai AE. 2012. MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson. 14(1):1–10.
  • Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Edgar R. 2007. NCBI GEO: mining tens of millions of expression profiles–database and tools update. Nucleic Acids Res. 35(suppl_1):D760–D765.
  • Bonilla JM, Tabanera MT, Mendoza LR. 2017. Breast cancer in the 21st century: from early detection to new therapies. Radiologia. 59:368–379.
  • Cassier PA, Treilleux I, Bachelot T, Ray-Coquard I, Bendriss-Vermare N, Menetrier-Caux C, Tredan O, Goddard-Leon S, Pin JJ, Mignotte H, et al. 2011. Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer. BMC cancer. 11:213.
  • Castaneda SA, Strasser J. 2017. Updates in the Treatment of Breast Cancer with Radiotherapy. Surg Oncol Clin N Am. 26:371–382.
  • Chen B, Xia Z, Deng YN, Yang Y, Zhang P, Zhu H, Xu N, Liang S. 2019. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis. Open Biol. 9:180212.
  • Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma’ayan A. 2013. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 14(1):1–14.
  • Fatima F, Saleem S, Hameed A, Haider G, Zaidi SAA, Kanwal M, Zehra S, Azhar A. 2019. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan. Mol Biol Rep. 46(2).
  • García-Tuñón I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M. 2004. Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study. Breast Cancer Res. 6(1):R1–R7.
  • Gravestein LA, Borst J. 1998. Tumor necrosis factor receptor family members in the immune system. Semin Immunol. 10:423–434.
  • Ho KH, Chang CJ, Huang TW, Shih CM, Liu AJ, Chen PH, Cheng KT, Chen KC. 2018. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set. PLoS One. 13:e0208459.
  • Hong C-C, Sucheston-Campbell LE, Liu S, Hu Q, Yao S, Lunetta KL, Haddad SA, Ruiz-Narváez EA, Bensen JT, Cheng T-YD, et al. 2018. Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomark Prev. 27:321–330.
  • Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57.
  • Huang S, Wei YK, Kaliamurthi S, Cao Y, Nangraj AS, Sui X, Chu D, Wang H, Wei DQ, Peslherbe GH, et al. 2020. Circulating miR-1246 Targeting UBE2C, TNNI3, TRAIP, UCHL1 Genes and Key Pathways as a Potential Biomarker for Lung Adenocarcinoma: Integrated Biological Network Analysis. J Pers Med. 10:162-162.
  • Kanehisa M, Goto S. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
  • Liu J, Liu Z, Zhou Y, Zeng M, Pan S, Liu H, Liu Q, Zhu H. 2021. Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer. Front Oncol. 11:666505.
  • Marotti JD, de Abreu FB, Wells WA, Tsongalis GJ. 2017. Triple-Negative Breast Cancer: Next-Generation Sequencing for Target Identification. Am J Pathol. 187:2133–2138.
  • Marra P, Mathew S, Grigoriadis A, Wu Y, Kyle-Cezar F, Watkins J, Rashid M, De Rinaldis E, Hessey S, Gazinska P, et al. 2014. IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers. Cancer Res. 74:4908–4921.
  • Méndez-García LA, Nava-Castro KE, Ochoa-Mercado TDL, Palacios-Arreola MI, Ruiz-Manzano RA, Segovia-Mendoza M, Solleiro-Villavicencio H, Cázarez-Martínez C, Morales-Montor J. 2019. Breast Cancer Metastasis: Are Cytokines Important Players During Its Development and Progression? J Interferon Cytokine Res. 39:39–55.
  • Mishan MA, Heirani-Tabasi A, Mokhberian N, Hassanzade M, Moghaddam HK, Bahrami AR, Ahmadiankia N. 2015. Analysis of Chemokine Receptor Gene Expression in Esophageal Cancer Cells Compared with Breast Cancer with Insights into Metastasis. Iran J Public Health. 44:1353–1358.
  • Nangraj AS, Selvaraj G, Kaliamurthi S, Kaushik AC, Cho WC, Wei DQ. 2020. Integrated PPI- and WGCNA-Retrieval of Hub Gene Signatures Shared Between Barrett's Esophagus and Esophageal Adenocarcinoma. Front Pharmacol. 11:881.
  • Peart O. 2015. Breast intervention and breast cancer treatment options. Radiol Technol. 86:535M–558M.
  • Qi F, Qin WX, Zang YS. 2019. Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathways. Oncol Lett. 17:2905–2914.
  • Rawlings-Goss RA, Campbell MC, Tishkoff SA. 2014. Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genomics. 7. doi:10.1186/1755-8794-1187-1153.
  • Ridings J, Macardle PJ, Byard RW, Skinner J, Zola H. 1995. Cytokine receptor expression by solid tumours. Ther Immunol. 2:67–76.
  • Segovia-Mendoza M, Morales-Montor J. 2019. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogens and Its Receptors Into Cancer Physiopathology. Front Immunol. 10. doi:10.3389/fimmu.2019.00348.
  • Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. 2021. Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches. F1000Res. 10:127.
  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504.
  • Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A. 2017. Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30.
  • Sonbul SN, Gorringe KL, Aleskandarany MA, Mukherjee A, Green AR, Ellis IO, Rakha EA. 2017. Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma. J Pathol Clin Res. 3:105–114.
  • Strien L, Joensuu K, Heikkilä P, Leidenius MH. 2017. Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases. Anticancer Res. 37:175–182.
  • Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M. 2015. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43:D447–D452.
  • Tsikitis VL, Potter A, Mori M, Buckmeier JA, Preece CR, Harrington CA, Bartley AN, Bhattacharyya AK, Hamilton SR, Lance MP, Thompson PA. 2016. MicroRNA Signatures of Colonic Polyps on Screening and Histology. Cancer Prev Res (Phila). 9:942–949.
  • Vahedi L, Ghasemi M, Yazdani J, Ranjbar S, Nouri B, Alizadeh A, Afshar P. 2018. Investigation of CCR7 Marker Expression Using Immunohistochemical Method and Its Association with Clinicopathologic Properties in Patients with Breast Cancer. Int J Hematol Oncol Stem Cell Res. 12:103–110.
  • Wang S, Liu J, Li C, Yang X. 2017. Research of the effect of miR-663 on the proliferation of prostate cancer cells, and the correlations of miR-663 with pathological grade and clinical stage. J BUON. 22:1011–1016.
  • Weigelt B, Peterse JL, Van't Veer LJ. 2005. Breast cancer metastasis: markers and models. Nat Rev Cancer. 5:591–602.
  • Xu B, Zhou M, Qiu W, Ye J, Feng Q. 2017. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway. Cancer Med. 6:1062–1071.
  • Xu F, Li D, Zhang Q, Fu Z, Yuan W, Pang D, Li D. 2012. Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province. Breast Cancer Res Treat. 133:1105–1113.
  • Zheng T, Wang A, Hu D, Wang Y. 2017. Molecular mechanisms of breast cancer metastasis by gene expression profile analysis. Mol Med Rep. 16:4671–4677.